Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03438227 · ClinicalTrials.gov registry record · Phase 4
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT03438227 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 38 participants.
The verdict
NCT03438227, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe, can have serious consequences for mothers and babies. While treatment of iron-deficiency anemia with iron supplementation is recommended, treatment strategies remain controversial: the American College of Obstetrics and Gynecology recommends oral iron supplementation with parental iron reserved for the rare patient who cannot tolerate or will not take oral iron, while United Kingdom professional organizations recommend a more liberal use of parenteral iron. The reason for these disparate recommendations is that few high-quality studies comparing oral to parenteral iron have been conducted in developed countries, and the potential impact of parental iron treatment on obstetric and perinatal outcomes remains unclear. We propose the first randomized-controlled trial in the United States describing the effectiveness and safety of treating pregnant women with iron-deficiency anemia with a protocol including parenteral iron compared with a protocol based on oral iron.
Interventions
- DRUG Ferrous sulfate 325mg
- DRUG Iron dextran
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03438227
The ClinicalTrials.gov registry entry for NCT03438227 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferrous sulfate 325mg is the first listed.
NCT03438227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03438227 about?
NCT03438227 is a clinical study titled "Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial". Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe, can have serious consequences for mothers and babies. While treatment of iron-deficiency anemia with iron supplementation is recommended, treatment strategies remain controversial: the American College of Ob...
What is the current status of trial NCT03438227?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2018-04-15. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03438227?
The interventions under investigation include: Ferrous sulfate 325mg (DRUG), Iron dextran (DRUG).
Who is sponsoring clinical trial NCT03438227?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.